Published summary: 2026-03-07
Where the evidence converges
Meta-analysis of pivotal trials found CBD has independent anti-seizure effects, though the benefit is amplified by interaction with clobazam
Strong evidence · 5 studies
Subgroup analyses were not pre-specified. Small numbers in non-clobazam subgroups. Meta-analysis of subgroups has inherent limitations.
A meta-analysis of 4 RCTs confirmed CBD significantly reduces seizures both with and without clobazam, though the effect was somewhat larger with clobazam
Strong evidence · 5 studies
Post-hoc stratified analysis of existing trials, not prospective; the difference in treatment ratios with/without clobazam could reflect a synergistic effect; cannot fully exclude confounding by cloba
Meta-analysis of 4 RCTs (714 patients) showed CBD reduced seizures in Dravet and Lennox-Gastaut syndrome regardless of whether patients were also taking clobazam
Strong evidence · 5 studies
Patients were not randomized to clobazam status (post-hoc subgroup analysis); limited sample sizes in subgroups; all trials used pharmaceutical-grade CBD (Epidiolex).
Where questions remain
Double-blind crossover study of 24 volunteers found CBD partially inhibits THC liver metabolism, though the effect was small relative to natural variation, and women achieved significantly higher THC blood levels than men
Moderate evidence · 27 studies
Large individual variation in pharmacokinetic data made it difficult to detect definitive effects. The doses used (10 mg THC, 5.4 mg CBD) may not represent all clinical scenarios. The study concluded
Year-long study found combined MDMA and cannabis users had sustained immune cell decreases and more infections, with cannabis-only users showing intermediate effects
Moderate evidence · 27 studies
Polydrug users often use additional substances not accounted for in this study. Self-reported drug use may be inaccurate. The observational design cannot confirm that drug use caused the immune change
Year-long study found ecstasy polydrug users showed mild cognitive decline while cannabis was paradoxically linked to faster brain processing speed on EEG measures
Moderate evidence · 27 studies
Very small sample sizes limit statistical power and generalizability. Ecstasy users were polydrug users, making attribution difficult. Self-reported drug use may be inaccurate. The paradoxical cannabi
A review described how chronic nicotine and alcohol each alter cannabinoid receptors, endocannabinoid content, and multiple other brain systems, reducing each other's withdrawal and increasing preference for combined use
Moderate evidence · 27 studies
Narrative review without systematic methodology. Many findings were from animal studies that may not translate to human experience. The complexity of multi-system interactions makes specific conclusio
Research gaps
- Long-term prospective studies tracking outcomes over 5+ years are largely absent from the literature.
- Research on diverse populations (different ages, ethnicities, and medical backgrounds) remains limited.
Key studies
CBD reduced seizures in both Dravet and Lennox-Gastaut syndromes, with enhanced effects when combined with clobazam
This meta-analysis directly addresses the critical question of whether CBD's seizure reduction is partly driven by its interaction with clobazam, showing CBD is effective in both clobazam users and the overall population, but more so in the combination.
CBD does have independent anti-seizure effects, though clobazam interaction boosts them
This addresses the critical question of whether CBD is truly anti-epileptic or merely boosting clobazam levels, concluding that both mechanisms contribute.
Meta-analysis of 4 RCTs confirms CBD reduces seizures with and without clobazam co-treatment
A persistent question has been whether CBD's seizure benefit depends on its interaction with clobazam rather than direct anticonvulsant effects. This meta-analysis demonstrates independent efficacy.
CBD works for seizures whether or not patients also take clobazam
A key debate in epilepsy medicine was whether CBD works on its own or only because it boosts clobazam blood levels through a drug interaction. This analysis suggests CBD has independent anti-seizure efficacy.
Phase 1 trial maps CBD drug interactions with three common epilepsy medications
These three AEDs are among the most commonly co-prescribed with CBD for Lennox-Gastaut and Dravet syndromes. Knowing that CBD triples the active clobazam metabolite is clinically actionable: clobazam doses may need reduction when adding CBD.
How Long Cannabis Shows Up in Urine — and Why Current Thresholds May Be Wrong
Urine testing is the most common form of cannabis detection in workplaces, criminal justice, and sport — affecting millions of people. This systematic review demonstrates that current thresholds often detect past use rather than recent consumption or impairment. For regular users trying to quit, wee
How the research developed
Pre-2000
3 studies published. Includes 2 RCTs.
2000–2009
7 studies published. Includes 1 RCTs.
2010–2014
19 studies published. Predominantly observational and review studies.
2015–2019
43 studies published. Includes 4 RCTs, 5 strong-evidence studies.
2020–present
88 studies published. Includes 4 meta-analyses, 7 RCTs, 13 strong-evidence studies.
How this summary was assembled
This consensus synthesizes 160 peer-reviewed studies: 4 meta-analyses (3%), 14 randomized controlled trials (9%), 28 observational studies (18%), 48 reviews (30%), 4 case studies (3%), 62 other study types (39%). Studies span from the earliest available research through 2025. Evidence strength ratings reflect study design, sample size, and replication across multiple research groups.
These counts describe the source summary at publication. They may differ from the current library.